| 0.00% |
| 4 | OSAIC HOLDINGS, INC. | 1.2M | $5.6M | +7.2% | 1.828% | 0.01% |
| 5 | MARSHALL WACE, LLP | 831K | $3.9M | -31.9% | 1.262% | 0.00% |
| 6 | GREAT POINT PARTNERS LLC | 800K | $3.7M | 0.0% | 1.215% | 0.70% |
| 7 | Wealthspire Advisors, LLC | 722K | $3.3M | 0.0% | 1.096% | 0.02% |
| 8 | STATE STREET CORP | 568K | $2.6M | +119.7% | 0.862% | 0.00% |
| 9 | CITADEL ADVISORS LLC | 539K | $2.5M | +48.3% | 0.818% | 0.00% |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | 407K | $1.9M | +10.9% | 0.618% | 0.00% |
| 11 | NORTHERN TRUST CORP | 387K | $1.8M | +196.3% | 0.587% | 0.00% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 366K | $1.7M | +20.5% | 0.556% | 0.00% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 328K | $1.5M | -69.4% | 0.498% | 0.00% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | 328K | $1.5M | — | 0.498% | 0.00% |
| 15 | TWO SIGMA INVESTMENTS, LP | 318K | $1.5M | -31.9% | 0.483% | 0.00% |
| 16 | LPL Financial LLC | 285K | $1.3M | +6.8% | 0.433% | 0.00% |
| 17 | Geneos Wealth Management Inc. | 240K | $1.1M | -0.2% | 0.365% | 0.02% |
| 18 | UBS Group AG | 219K | $1.0M | +22.0% | 0.333% | 0.00% |
| 19 | RETIREMENT GUYS FORMULA LLC | 211K | $979K | +12.8% | 0.321% | 0.37% |
| 20 | Sovran Advisors, LLC | 258K | $875K | +0.1% | 0.392% | 0.07% |
| 21 | NATIONAL BANK OF CANADA /FI/ | 168K | $779K | — | 0.255% | 0.00% |
| 22 | BLAIR WILLIAM & CO/IL | 149K | $693K | 0.0% | 0.227% | 0.00% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 116K | $540K | +288.0% | 0.177% | 0.00% |
| 24 | Bank of New York Mellon Corp | 106K | $491K | — | 0.161% | 0.00% |
| 25 | HighTower Advisors, LLC | 94K | $437K | +0.8% | 0.143% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in GALT — a direct measure of their conviction.
| 16.57% |
| 2.47 pp |
| $12M |
| 27% |
| Q4 2024 | 92 | +15% | 19.04% | +2.79 pp | $17M | 36% |
| Q3 2024 | 80 | — | 16.25% | — | $26M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
19 institutions opened new positions in GALT during Q2 2026, while 18 fully exited. 70 added to existing positions and 8 trimmed.
GALT institutional ownership rose by 2.16 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 69.4% of all reported 13F value in GALT, and the top 25 account for 90.5%.
Across the largest Metabolic & Cardiovascular Biotech peers, institutional ownership levels are: EOCN (1.3%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.